IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)
96.82
-1.43 (-1.46%)
Aug 22, 2025, 3:30 PM IST
NSE:IOLCP Revenue
IOL Chemicals and Pharmaceuticals had revenue of 5.52B INR in the quarter ending June 30, 2025, with 9.82% growth. This brings the company's revenue in the last twelve months to 21.29B, up 2.73% year-over-year. In the fiscal year ending March 31, 2025, IOL Chemicals and Pharmaceuticals had annual revenue of 20.79B, down -2.51%.
Revenue (ttm)
21.29B
Revenue Growth
+2.73%
P/S Ratio
1.34
Revenue / Employee
7.36M
Employees
2,891
Market Cap
28.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 20.79B | -535.80M | -2.51% |
Mar 31, 2024 | 21.33B | -843.20M | -3.80% |
Mar 31, 2023 | 22.17B | 330.90M | 1.52% |
Mar 31, 2022 | 21.84B | 2.17B | 11.03% |
Mar 31, 2021 | 19.67B | 725.10M | 3.83% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
IOL Chemicals and Pharmaceuticals News
- 17 days ago - IOL Chemicals shares surge nearly 3.5% after Q1 profit rises 13% YoY - Business Upturn
- 17 days ago - IOL Chemicals Q1 results: Net profit rises 13% YoY to Rs 34 crore; EBITDA margin improves to 11.4% - Business Upturn
- 4 months ago - IOL Chemicals and Pharmaceuticals shares jump nearly 5% after China approves Ibuprofen export - Business Upturn
- 4 months ago - Why are IOL Chemicals share price falling 3% today? Check here - Business Upturn
- 6 months ago - IOL Chemicals shares surge 4% after EDQM certification for Quetiapine Fumarate - Business Upturn
- 8 months ago - IOL Chemicals and Pharmaceuticals shares rise nearly 4% as board approves 1:5 stock split - Business Upturn
- 8 months ago - IOL Chemicals shares surge 7% after company plans to consider stock split - Business Upturn
- 9 months ago - IOL Chemicals & Pharmaceuticals shares fall nearly 5% after disappointing Q2 FY25 results - Business Upturn